BioCryst Pharmaceuticals, Inc. BCRX
7.69 USD +0.06 (+0.79%)
At closeNov 9, 2026, 4:59 AM EST
7.71 +0.02 +0.26%
Pre-market · Nov 9, 4:59 AM ET
7.38 Day range 7.83
6.23 52-week range 11.22
- YTD
- -1.41%
- 1 year
- +9.39%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 874.84M | 450.71M | 331.41M | 270.83M | 157.17M | |
| 874.84M | 450.71M | 331.41M | 270.83M | 157.17M | |
| 19.07M | 12.27M | 4.48M | 6.59M | 7.26M | |
| 855.76M | 438.44M | 326.93M | 264.23M | 149.91M | |
| 514.77M | 440.99M | 430.64M | 412.67M | 327.63M | |
| 166.13M | 174.64M | 216.57M | 253.30M | 208.81M | |
| 348.65M | 266.35M | 214.07M | 159.37M | 118.82M | |
| 340.99M | -2.54M | -103.71M | -148.44M | -177.72M | |
| 78.87M | 98.52M | 108.24M | 99.09M | 59.29M | |
| 3.53M | 1.93M | 310.00K | 2.73M | 2.25M | |
| 263.86M | -88.88M | -226.54M | -247.12M | -184.06M | |
| 263.86M | -88.88M | -226.54M | -247.12M | -184.06M | |
| 263.86M | -88.88M | -226.54M | -247.12M | -184.06M | |
| 263.86M | -88.88M | -226.54M | -247.12M | -184.06M | |
| 1.26 | -0.43 | -1.18 | -1.33 | -1.03 | |
| 1.26 | -0.43 | -1.18 | -1.33 | -1.03 | |
| 1.21 | -0.43 | -1.18 | -1.33 | -1.03 | |
| 346.26M | 11.56M | -117.99M | -145.29M | -122.52M | |
| 346.26M | 11.56M | -117.99M | -145.29M | -122.52M | |
| 209.89M | 206.70M | 192.20M | 185.91M | 179.12M | |
| 218.58M | 206.70M | 192.20M | 185.91M | 179.12M |